Tirzepatide, a groundbreaking therapy, represents a significant innovation in the approach of type 2 blood sugar issues and, more recently, obesity. This dual agonist acts upon two crucial receptors: glucagon-like peptide-1 and gastric inhibitory polypeptide. Unlike traditional medications for diabetes, Tirzepatide promotes not only insulin secreti